your market intelligence analyst
Search Results
389 results
Your search is now limited to «Latest News on Diabetes Drugs» expert search.
ETHealthWorld (India) 08/19/2019 05:18
Glenmark receives regulatory nod to market combination drug for diabetes in India, Health News, ET HealthWorld.
More from ETHealthWorld (India):
FeedNavigator (EU) 08/19/2019 02:09
Insulin Participants randomised to insulin treatment will receive insulin according to usual practice, that is, in incremental doses until glycaemic targets are met.41 This includes both short-acting and long-acting insulin.
More from FeedNavigator (EU):
Human medicines European public assessment report (EPAR): NovoMix, insulin aspart, Diabetes Mellitus, Date of authorisation: 01/08/2000, Revision: 27, Status: Authorised.
More from European Medicines Agency - EMEA (EU):
Business Insider 08/16/2019 10:51
Ken Inchausti, a spokesman for Novo Nordisk, which sells human insulin at affordable, over-the-counter rates, told INSIDER that human insulin "is safe and effective and is used by millions of Americans who depend on it for the treatment of type 1 and type 2 diabetes ...
More from Business Insider:
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
More from International Journal of COPD:
Healio News 08/11/2019 12:02
Nearly a third of people with diabetes may inappropriately omit insulin to lose weight.
More from Healio News: 08/09/2019 09:34
REUTERS/Guillaume Souvant/Pool/File Photo The Danish company is pinning its hopes on a relatively new treatment for type 2 diabetes as its older insulin drugs face political pressure over the soaring cost of the life-sustaining medicine in the United States.
More from (UK) 08/05/2019 20:00
The insulin combines a mix of a short-acting 'regular' insulin and an intermediate acting 'isophane' insulin.
More from (UK):
A 27-year-old man died in the midst of a diabetic coma in June after the cheaper insulin he switched to months earlier failed him.
More from Mail on Sunday (United Kingdom):
In children and adolescents with type 1 diabetes, insulin pumps have been shown to have several benefits in areas like blood glucose control and cardiovascular outcomes.
More from Diabetes Self-Management - blog:
ENDPOINTS 08/05/2019 10:09
AstraZeneca‘s $AZN SGLT2 diabetes drug, dapagliflozin, has won a label upgrade courtesy of the EMA.
More from ENDPOINTS:
Daily Excelsior (India) 08/02/2019 14:16
Saroglitazar Magnesium was launched in India during September 2013, under the brand name ‘Lipaglyn’, for the treatment of hypertriglyceridemia and diabetic dyslipidemia in patients with type 2 diabetes not controlled by statins.
More from Daily Excelsior (India): 08/02/2019 08:04
Condition : Diabetes Mellitus, Type 2 Intervention : Drug: Insulin Degludec/Insulin Aspart Sponsor : Novo Nordisk A/S Enrolling by invitation.
More from
The growing prevalence of health related disorders such as obesity and diabetes has led to an increase in the demand for ready-to-use insulin for intra venous (IV) infusion.
More from Middle East North Africa Financial Network (MENAFN):
Business Wire 08/01/2019 16:02
The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin.
More from Business Wire:
PubMed News (NIH) 07/31/2019
Contributors : Taiyi D Kuo ; Domenico Accili Series Type : Expression profiling by high throughput sequencing Organism : Mus musculus. To investigate the function of C2CD4A, we analyzed RNA profiles in MIN6 cells expressing C2cd4a-GFP or control-GFP.
More from PubMed News (NIH):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications